Balyasny Asset Management’s Lifestance Health LFST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$4.78M Buy
+397,592
New +$4.69M 0.01% 1455
2026
Q2
– Sell
-391,149
Closed -$2.49M – 3287
2026
Q1
$2.49M Buy
391,149
+352,372
+909% +$2.45M ﹤0.01% 1687
2025
Q4
$273K Buy
+38,777
New +$234K ﹤0.01% 2763
2025
Q3
– Sell
-63,727
Closed -$329K – 3216
2025
Q2
$329K Buy
63,727
+46,740
+275% +$280K ﹤0.01% 2449
2025
Q1
$113K Buy
+16,987
New +$129K ﹤0.01% 2673
2023
Q2
– Sell
-11,362
Closed -$84.4K – 2558
2023
Q1
$84.4K Buy
+11,362
New +$63K ﹤0.01% 2335
2021
Q3
– Sell
-125,000
Closed -$3.48M – 2204
2021
Q2
$3.48M Buy
+125,000
New +$3.3M 0.02% 829

Other funds holding LFST

Balyasny Asset Management's LFST Position: Q3 2026 in Review

Balyasny Asset Management opened a new position in Lifestance Health (LFST) in Q3 2026: 397,592 shares worth $4.78M. The stake represents 0.01% of the portfolio and ranks #1455 among its holdings. This is a return to the name: Balyasny Asset Management previously reported a position in LFST as recently as Q1 2026.

Balyasny Asset Management first reported a position in LFST in Q2 2021 and has held it in 7 quarters since. 326 funds tracked by Wall St. Rank hold LFST as of Q3 2026.

  • Balyasny Asset Management held 397,592 shares of Lifestance Health worth $4.78M as of Q3 2026.
  • Lifestance Health was a new Balyasny Asset Management position in Q3 2026.
  • Lifestance Health made up 0.01% of Balyasny Asset Management's portfolio in Q3 2026, its #1455 holding.
  • Balyasny Asset Management first reported a position in Lifestance Health in Q2 2021 and has held it in 7 quarters since.
  • 326 funds tracked by Wall St. Rank held Lifestance Health as of Q3 2026.

Based on Balyasny Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.